The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Aims/Purpose: To compare lesion reactivation and treatment outcomes between pure type 2 and mixed type 1 and 2 macular neovascularization (MNV) treated with anti‐vascular endothelial growth factor (VEGF).
Methods: This retrospective study included 155 patients diagnosed with Type 2 MNV. After the initial loading injections, as‐needed retreatment was provided. The difference in first lesion reactivation...
Purpose
To investigate the long‐term clinical course after vitrectomy for breakthrough vitreous hemorrhage secondary to neovascular age‐related macular degeneration (AMD).
Methods
This retrospective study included 45 eyes that underwent vitrectomy due to breakthrough vitreous hemorrhage secondary to neovascular AMD. The patients were divided into two groups: typical neovascular AMD group and polypoidal...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.